BioMelbourne Network
Progressing BioIndustry
News and Opinions
2013
February
Phylogica and Bio-Link Collaborate to Commercialise Anti-Inflammatory Phylomers
February 5 2013. Phylogica Ltd (ASX: PYC, XETRA: PH7), a leading Australian peptide drug discovery company, announced today that it has entered an agreement with Bio-Link Australia Pty. Ltd., a specialist life sciences business development company, to commercialise a family of anti-inflammatory PhylomerÒ peptides for pharmaceutical use. Under the terms of the agreement, Bio-Link will work with... read more…
January
Allied closes SPP, bringing total capital raised to $4.6M
January 23 2013. Allied Healthcare Group (ASX: AHZ) today announced it has closed its Share Purchase Plan (SPP), raising $2.9M. Together with the $1.7M placement completed in December 2012, Allied has raised a total of over $4.6M, placing the company in a strong position for 2013.“We welcome the new shareholders participating in the placement and appreciate the ongoing support of our exist... read more…
Phosphagenics Initiates Clinical Program with Oxymorphone TPM® Patch
16th January, 2013
• Expansion of pain portfolio to include Oxycodone and Oxymorphone• Oxymorphone Phase 1trial to begin February 2013 Royal Adelaide Hospital16 January 2013, Melbourne, Australia: Melbourne drug delivery technology company, Phosphagenics Limited (ASX: POH, OTCQX: PPGNY), will launch a Phase 1 study of a transdermal patch incorporating the powerful opioid oxymorphone in early F... read more…
Burnet's CD4 Test: On the Frontline
By Tracy Parish14 January, 2013 “It’s easy to diagnose HIV but it’s hard to identify those who need therapy. Our test will change that, providing cost-effective testing for up to 33 million patients worldwide.” — Associate Professor David Anderson, Burnet Institute.
After six years of development in the laboratory, Burnet scientists have developed the VISITECT® CD4, an affordable point-of-care... read more…
Academic and biotechnology industry alliance wins $300,000 grant
15th January, 2013 - Academic and biotechnology industry alliance wins $300,000 grant
The Victorian government has provided $300,000 to the Victorian Infection and Immunity Network (VIIN) as part of its Collaborative Networks Pilot Program, to encourage the development of partnerships between academic and industry groups and to accelerate industry’s adoption of new technologies.
The VIIN is j... read more…
Bluechiip signs Micronic America
Monday 14 January 2013,Bluechiip Limited [ASX: BCT] today announced it has signed a Distribution Agreement with Micronic America LLC. The agreement gives Micronic America and its network of distributors, including E&K Scientific, USA Scientific, Nova Biostorage Plus (formerly Micronic North America), MJS Biolynx and D-Mark Biosciences, the rights to distribute Bluechiip’s products throughout th... read more…
R&D Tax Incentive Drives Investment
11 January 2013. Australian small and medium sized businesses have received around $500 million in direct payments during the first six months of the Gillard Labor Government’s new R&D Tax Incentive.
Under the new program, smaller businesses (with a turnover of less than $20 million per annum) engaged in eligible R&D can receive a 45 per cent refundable tax offset. For those companies in tax l... read more…
ASX Announcement - Allied’s ADAPT®- treated tissue shows advantages for abdominal hernia and pelvic floor reconstructions
10th January, 2013
* Allied’s ADAPT®-treated tissue demonstrates positive results of tissue repair in abdominal hernia and pelvic floor reconstructions* ADAPT®-treated tissue showed no evidence of infections, erosions or resorption in the hernia repairs* ADAPT®-treated tissue demonstrated reduced infections, erosions and provided evidence of resorption in the pelvic floor* The study was under... read more…
2012
December
NHMRC Grant for Ian Frazer's Work on Next-Gen HPV Vaccine
December 20 2012. Allied Healthcare Group (AHZ) today announced Professor Ian Frazer has been awarded a grant to support the ongoing development of a novel DNA vaccine for the prevention and treatment of human papilloma virus (HPV).Professor Frazer, and his team at the University of Queensland, will receive funding from Australia’s National Health and Medical Research Council (NHMRC) of $200,0... read more…
$1.2 million for networks to link industry and research
December 19 2012. Four projects will receive a total of $1.2 million as part of the Victorian Coalition Government’s Collaborative Networks Pilot Program, Minister for Innovation, Services and Small Business Louise Asher announced today.Ms Asher said the Collaborative Networks Pilot Program was an initiative of the Coalition Government to support the commercialisation and adoption of new techn... read more…
